CA545197A - Cristallisation - Google Patents

Cristallisation

Info

Publication number
CA545197A
CA545197A CA545197A CA545197DA CA545197A CA 545197 A CA545197 A CA 545197A CA 545197 A CA545197 A CA 545197A CA 545197D A CA545197D A CA 545197DA CA 545197 A CA545197 A CA 545197A
Authority
CA
Canada
Prior art keywords
crystallization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA545197A
Other languages
English (en)
Inventor
V. Wakefield Ralph
J. Mulqueeny Thomas
Original Assignee
Olin Corp
Publication date
Application granted granted Critical
Publication of CA545197A publication Critical patent/CA545197A/fr
Expired legal-status Critical Current

Links

CA545197A Cristallisation Expired CA545197A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA545197T

Publications (1)

Publication Number Publication Date
CA545197A true CA545197A (fr) 1957-08-20

Family

ID=35702374

Family Applications (1)

Application Number Title Priority Date Filing Date
CA545197A Expired CA545197A (fr) Cristallisation

Country Status (1)

Country Link
CA (1) CA545197A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248601A (en) * 1979-07-12 1981-02-03 Kerr-Mcgee Chemical Corporation Process for reducing the sodium chloride content of a potassium salt

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248601A (en) * 1979-07-12 1981-02-03 Kerr-Mcgee Chemical Corporation Process for reducing the sodium chloride content of a potassium salt

Similar Documents

Publication Publication Date Title
CA547128A (fr) Pyrrolecarboxamidopyrroles substitues
CA545197A (fr) Cristallisation
CA537472A (fr) Benzamidopropylamines substituees
CA540469A (fr) Glycinamides substitues
CA545412A (fr) Procede de cristallisation
CA538308A (fr) Glycinamides substitues
CA547251A (fr) Iminodibenzyles substitues
CA540468A (fr) Glycinamides substitues
CA537471A (fr) Alkoxybenzylisoquinolines substitues
CA540470A (fr) Glycinamides substitues
CA540471A (fr) Glycinamides substitues
CA544933A (fr) 3-morpholones substitues
CA545344A (fr) Glycinamides substitues
AU226676B2 (en) Substituted coumarones
CA547129A (fr) Carbonylaminomethylepyrroles substitues
AU223918B2 (en) Fodder-well
AU225735B2 (en) Swim-float
AU217713B2 (en) DEXTRO-ROTARY N-ETHYL-a METHYLPHENETHYLAMINE
AU218135B2 (en) Relay-strips
AU220047B2 (en) Surgical-needle
AU220305B2 (en) Bolomneters
AU220534B2 (en) Shear-action wire-connector
AU222039B2 (en) p-aminobenzenesulphonamido-isothiazoles
AU223412B2 (en) 5-aminoisothiazoles
CA535266A (fr) 5-chloro-2-d-galactobenzimidazole